Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (Weighted Average) (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $71.5 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Outstanding (Weighted Average) rose 140.49% year-over-year to $71.5 million, compared with a TTM value of $71.5 million through Sep 2023, up 140.49%, and an annual FY2022 reading of $36.0 million, up 58.69% over the prior year.
  • Shares Outstanding (Weighted Average) was $71.5 million for Q3 2023 at Terns Pharmaceuticals, roughly flat from $71.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $71.5 million in Q3 2023 and bottomed at $215890.0 in Q1 2020.
  • Average Shares Outstanding (Weighted Average) over 4 years is $27.6 million, with a median of $25.1 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 8218.01% in 2021, then rose 18.27% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $285162.0 in 2020, then surged by 7862.47% to $22.7 million in 2021, then soared by 58.69% to $36.0 million in 2022, then soared by 98.51% to $71.5 million in 2023.
  • Business Quant data shows Shares Outstanding (Weighted Average) for TERN at $71.5 million in Q3 2023, $71.4 million in Q2 2023, and $69.8 million in Q1 2023.